Printer Friendly

Progress toward poliomyelitis eradication - Africa, 1996.

In 1988, the World Health Assembly established a goal of eradicating poliomyelitis worldwide by the year 2000 (1). The four strategies recommended by the World Health Organization (WHO) for polio eradication are 1) achieving and maintaining high routine vaccination coverage levels among children aged [less than] 1 year with at least three doses of oral poliovirus vaccine (OPV); 2) developing sensitive systems of epidemiologic and laboratory surveillance, including establishing acute flaccid paralysis (AFP) surveillance(*); 3) administering supplementary doses of OPV to all young children (usually those aged [less than] 5 years) during National Immunization Days([dagger]) (NIDs) to rapidly interrupt wild poliovirus transmission; and 4) conducting "mopping-up" vaccination campaigns--localized campaigns targeting high-risk areas where poliovirus transmission is most likely to persist at low levels. Eradicating polio from Africa remains one of the major challenges to global eradication by the target date. This report summarizes progress achieved in 1996 toward polio eradication in Africa with the implementation of supplemental vaccination activities; the reported OPV coverage during the NIDs or Subnational Immunization Days (SNIDs) was [greater than]80% in the target age group in most countries (Table 1), and the estimated cost was 50[cts.] per child vaccinated during NIDs.

TABLE 1. Reported coverage with oral poliovirus vaccine during each round of National Immunization Days (NIDs)* or Subnational Immunization Days (SNIDs), by country-African Region, World Health Organization, January 1996-March 1997
Supplemental activity/              Reported coverage (%)([dagger])
Country                            First round          Second round

NIDs

Algeria                                89                  90
Angola                                 71                  80
Benin                                 103                  91
Botswana                               97                  99
Burkina Faso                           93                 107
Cameroon                               NA([subsections])   NA
Central African Republic([paragraph])  NA                  NA
Chad(**)                               83                  NA
Congo                                  82                  91
Cote d'Ivoire                          80                  97
Equatorial Guinea                      89                 105
Eritrea                                61                  72
Ghana                                  90                  96
Kenya                                  79                  81
Lesotho                                51                  52
Malawi                                 74                  86
Mauritania                             89                  95
Namibia                                88                 101
Nigeria                                47                  64
Rwanda                                 53                  62
South Africa                           90                  77
Swaziland                              82                  85
Tanzania                               97                 102
Togo                                   83                  96
Uganda                                 95                  94
Zambia                                 87                  88
Zimbabwe                               96                  96

SNIDs
Ethiopia                               96                 104
Gabon                                  78                  82
Mozambique                             81                  81
Zaire                                  88                  88


(*) Mass campaigns over a short period (days to weeks) in which two doses of OPV are administered to all children in the target age group, regardless of prior vaccination history, with an interval of 4-6 weeks between doses.

([dagger]) Reported coverage may exceed 100% because of uncertainty about target population (denominator problem) or vaccination of children outside the target age (numerator problem.)

([subsections]) Not available.

([paragraph]) The first of NIDs was March 25-27, 1997, and data are incomplete.

(**) The first round of NIDs was March 3-8, and the second was March 31-April 5, 1997.

In 1995, a total of 2192 polio cases were reported from the 46 countries in the African Region of WHO. During the same year, 16 countries, including four of the largest (Angola, Ethiopia, Nigeria, and Zaire), reported that [is less than]50% of children had received three doses of OPV through routine vaccination services.

The first round of NIDs and SNIDs in the African Region (Figure 1) were conducted from January 1996 through March 1997. In the largest series of vaccination days conducted in Africa during a single year, approximately 74 million children--approximately three fourths of all children aged [less than] 5 years in Africa--were targeted to receive supplemental doses of OPV. By March 1997, a total of 31 countries had finished or were completing these supplemental vaccination activities; NIDs were being or had been conducted in 27 (87%) countries, and SNIDs were conducted in four (13%)--Gabon (targeting 23% of all children aged [less than] 5 years), Zaire (21%), Mozambique (16%), and Ethiopia (3%). SNIDs in the larger countries with difficult circumstances (Ethiopia and Zaire) served a dual purpose of providing supplemental OPV doses to urban children at highest risk for polio and strengthening planning and logistics for the 1997 vaccination days.

[Figure 1 ILLUSTRATION OMITTED]

Reported OPV coverage after each round of NIDs or SNIDs was [greater than or equal to] 80% in the target age group in most countries (Table 1). OPV coverage of [greater than] 80% during at least one round was reported from Angola, Eritrea, Gabon, Kenya, Lesotho, Malawi, Nigeria, Rwanda, and South Africa; coverage data were unavailable from Cameroon and Central African Republic.

The first round of vaccination days reached approximately 80% of the target children in most countries, and reported coverage was higher in the second round in almost every country. For 20 countries with information about the total number of children who were vaccinated in both rounds, 18 (90%) of 20 countries reached more children in the second round; in 10 (50%) of 20 countries, the coverage in the second round was at least 5% higher than in the first round. In Nigeria, OPV coverage increased by 17 percentage points in the second round (64%) compared with the first round (47%). Of the 32 states in Nigeria, 11 were selected and provided technical assistance by WHO and the United Nations Children's Fund (UNICEF). In these 11 states, coverage in the first round was 63% and in the second round was 93%.

During April-December 1997, supplemental vaccination activities for polio eradication will be conducted for the first time in Burundi, Gambia, Guinea, Guinea-Bissau, Liberia, Madagascar, Mali, Niger, Senegal, and Sierra Leone. This will bring the total number of countries participating to 41 of the 46 countries in the African Region. In addition, Ethiopia, Gabon, and Mozambique will conduct NIDs, and countries that conducted NIDs in 1996 plan to conduct NIDs in 1997. Zaire may extend SNIDs to target half the country.

Surveillance for AFP and wild poliovirus began in approximately half of the countries in 1996. Wild poliovirus genomic sequencing was performed on at least one poliovirus isolate from each of 14 countries, including the four countries with difficult circumstances--Angola, Ethiopia, Nigeria, and Zaire.

The preliminary estimate of direct external and in-country costs averaged approximately 50[cts.] per child vaccinated during the NIDs. Government in-kind contributions to NIDs, which were substantial in some countries, were not included in the cost calculations; therefore, the total cost per child vaccinated is an underestimate. Most external support was provided by Rotary International, UNICEF, WHO, and the U.S. government through the U.S. Agency for International Development and CDC. Cost data for SNIDs were not available. Reported by: Regional Office for Africa, World Health Organization, Brazzaville, Congo; Global Program on Vaccines and Immunization, World Health Organization, Geneva, Switzerland. Respiratory and Enterovirus Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases; Polio Eradication Activity, National Immunization Program, CDC. Editorial Note: During 1996, NIDs were implemented in all countries in Europe and Asia where polio is endemic (2,3) and, for the first time, in many countries in the African Region. The initial experience with NIDs, conducted through the combined efforts of local and national governments and international partners, indicates that NIDs can be undertaken at modest costs in the African Region. Through the polio-eradication initiative, resources have been mobilized in support of enhanced planning, management, social mobilization, surveillance, and national and local political action for national vaccination programs (4,5). The strengthening of surveillance and other support systems is facilitating the development of the capacity for enhanced reduction of measles mortality; acceleration of neonatal tetanus elimination; and enhanced control of yellow fever, hepatitis B, epidemic meningitis, and other emerging or reemerging diseases (J.M. Okwo-Bele, Regional Office for Africa, World Health Organization, personal communication, 1997).

Because population densities in Benin, Cameroon, Chad, Niger, and Nigeria and along the West African coast may form a geographically contiguous epidemiologic block, interruption of wild poliovirus transmission in this block is dependent on progress in vaccinating susceptible populations in each of these areas. Zaire also is important in polio-eradication efforts because wild polioviruses isolated during 1993-1995 in the surrounding countries of Angola, Namibia, Tanzania, and Zambia have been linked to earlier wild polioviruses isolated in Zaire (J.M. Okwo-Bele, Regional Office for Africa, World Health Organization, personal communication, 1997). Zaire, where polio is endemic, is the only country in the region that does not plan to conduct NIDs in 1997. Challenges in the African Region for 1997 are to ensure that all countries with endemic polio conduct NIDs (including those that experience internal strife and civil war), that routine vaccine coverage improves concurrently to approach or exceed the levels reported during the NIDs, and that sensitive surveillance systems for polio are implemented in all countries, including the approximately 4000 districts in the region. Surveillance for AFP and wild poliovirus will be used to monitor the progress in interrupting viral transmission and document the absence of wild poliovirus from the region and achieve polio eradication. The progress in the African Region suggests that, with continued efforts in implementing NIDs in all countries where polio is endemic, polio may be eradicated from the continent by the year 2000.

(*) A confirmed case of polio is defined as acute flaccid paralysis and at least one of the following: 1) laboratory-confirmed wild poliovirus infection, 2) residual paralysis at 60 days, 3) death, or 4) no follow-up investigation at 60 days.

([dagger]) Mass campaigns over a short period (days to weeks) in which two doses of OPV are administered to all children in the target age group, regardless of prior vaccination history, with an interval of 4-6 weeks between doses

References

[1.] World Health Assembly. Global eradication of poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. Geneva, Switzerland: World Health Organization, 1988 (Resolution no. WHA 41.28).

[2.] Hull HF, Ward NA, Hull BP, Milstien JB, de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994;343:1331-7.

[3.] CDC. Progress toward global eradication of poliomyelitis, 1995. MMWR 1996;45:565-8.

[4.] World Health Organization. Summary of the Third Meeting of the Africa Regional Inter-Agency Coordination Committee, Dakar, Senegal, December 5-7, 1996. Brazzaville, Congo: Regional Office for Africa, World Health Organization, 1996.

[5.] Okwo-Bele JM, Lobanov A, Biellik RJ, et al. Overview of poliomyelitis in the African region and current regional plan of action. J Infect Dis 1997;175:S10-S15.
COPYRIGHT 1997 U.S. Government Printing Office
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Morbidity and Mortality Weekly Report
Date:Apr 18, 1997
Words:1676
Previous Article:Hepatitis A associated with consumption of frozen strawberries - Michigan, March 1997.
Next Article:Update: influenza activity - United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |